Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Journal of Medical Economics|March 2, 2013
Posaconazole vs fluconazole/itraconazole in the prophylaxis of invasive fungal infections in immunocompromised patients: a cost-effectiveness analysis in GreeceK Athanasakis, I Petrakis, J KyriopoulosJournal of Musculoskeletal & Neuronal Interactions|December 5, 2017
Cost-effective osteoporosis treatment thresholds for people living with HIV infection in GreeceP Makras, N Boubouchairopoulou, I Katsarolis, et al.Health Policy (Amsterdam, Netherlands)|January 23, 2017
Why do generic drugs fail to achieve an adequate market share in Greece? Empirical findings and policy suggestionsT Balasopoulos, A Charonis, K Athanasakis, et al.Hippokratia|January 7, 2014
Trends of mortality in Greece 1980-2007: a focus on avoidable mortalityM Ollandezos, Th Constantinidis, K Athanasakis, et al.The Journal of Hospital Infection|December 18, 2019
Costs associated with measles in healthcare personnel during the 2017-2018 epidemic in Greece: a real-world data cost-of-illness analysisH C Maltezou, X Dedoukou, E Pavi, et al.Diabetic Medicine : a Journal of the British Diabetic Association|June 16, 2010
Estimating the direct cost of Type 2 diabetes in Greece: the effects of blood glucose regulation on patient costK Athanasakis, M Ollandezos, A Angeli, et al.Hippokratia|February 9, 2018
The Atrial Fibrillation Effect on QualiTy-of-Life (AFEQT) questionnaire: cultural adaptation and validation of the Greek versionP Tailachidis, Z Tsimtsiou, P Galanis, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|March 6, 2015
Cost-effective osteoporosis treatment thresholds in GreeceP Makras, K Athanasakis, N Boubouchairopoulou, et al.Lupus|April 9, 2016
Clinical and financial burden of active lupus in Greece: a nationwide studyG Bertsias, E Karampli, P Sidiropoulos, et al.Pageof 1